Daily TIP

UN nuclear agency finds Iran violated nuclear deal. Again.

Posted by Tip Staff - November 18, 2016


 

The United Nations’ nuclear agency announced Thursday that for the second time since the implementation of the Iran nuclear deal in January, Iran has violated its limits on stockpiling “heavy water,” a component that can be combined with uranium to produce weapons-grade plutonium.
The head of the IAEA, Yukiya Amano, warned Iran of the dangers of noncompliance with the agreement:
“It is important that such situations should be avoided in future in order to maintain international confidence in the implementation of the [deal], which represents a clear gain for nuclear verification in Iran.”
The latest Iranian violation was initially reported last week, just days after an Iranian parliamentary claimed that it was abiding by the terms of the deal.

 

The Israel Defense Forces is making cautionary plans for if (and most likely when) Hezbollah triggers a new war, Haaretz reported Friday. As many as 78,000 Israeli civilians will have to be evacuated in the event of a conflict – a deviation from traditional Israeli military doctrine, which is averse to withdrawing civilians in the face of enemy attack.
“It is necessary to weigh things carefully, without tying ourselves up in doctrinal knots. During fighting, the IDF has to ensure delivery of vital services to locales under attack, provide them with warnings of rocket fire in their area and save the lives of people who have been hit,” said Col. Itzik Bar, commander of the northern district of Central Command. “When the threat level in a community adjacent to the border is so high that it is difficult for you to promise this, the right thing will be to act in a different way and consider evacuation.”
The army’s new plan accounts for an estimated 40 percent of residents leaving independently. Others will need help.
Lebanon recently elected Gen. Michael Aoun to the presidency – a Hezbollah ally who promptly threatened Israel in his inaugural address. He vowed to protect Lebanon from Israel in a “preemptive manner.”

 

A delegation of Israeli parliamentarians met with counterparts from the European Parliament and called for closer ties in a number of areas.
The meeting took place on Thursday at the European Parliament in Brussels. Yesh Atid MK and former Science Minister Yaakov Peri, along with Kulanu MKs Eli Alalouf and Merav Ben-Ami, met a delegation of MEPs led by Italian MEP Fulvio Martusciello, chair of the European Parliament delegation for relations with Israel.
The two delegations discussed a range of topics, including the peace process between Israel and the Palestinians and issues concerning immigration and asylum seekers. The also discussed a number of security challenges, particularly cyber-security and the shared terrorist threat.
“The major issues under discussion included the continued rise of religiously motivated terrorism and extremism as well as the increase in antisemitism and hate crimes in Europe,” a joint statement released after the meeting said. “These significant challenges demand joint deliberation, information-sharing and an examination of the ways to address and combat these phenomena.”

 

Israel-based medical device company, Tyto Care, has announced that its digital stethoscope has been granted US Food and Drug Administration (FDA) clearance. The stethoscope device will be part of Tyto Care’s advanced set of examination tools now being introduced to the telehealth arena. At present, telehealth is somewhat limited because clinicians rely on phone or video conferencing only to examine and diagnose a patient, without the benefit of a physical exam. By providing vital physical exam data, Tyto extends the reach of the clinician beyond the four walls of the clinic. “For the first time we are making it possible to closely replicate, from home, a face-to-face visit to the doctor’s office,” said Dedi Gilad, CEO and co-founder of Tyto Care. “Tyto is providing the missing link that will help telehealth realize its full potential.” (via Israel 21c)


Be the first to comment

Please check your e-mail for a link to activate your account.